Year :
2022
| Month :
May
| Volume :
16
| Issue :
5
| Page :
BD01 - BD03
Full Version
A Rare Case Report of a 8-weeks-old
Infant with Hypercalcaemia and Subcutaneous Fat Necrosis
Published: May 1, 2022 | DOI: https://doi.org/10.7860/JCDR/2022/54891.16405
KS Manjula, KV Shweta, AN Shruthi, E Adarsh, K Shasikala
1. Associate Professor, Department of Biochemistry, Rajarajeswari Medical College and Hospital, Bengaluru, Karnataka, India.
2. Assistant Professor, Department of Biochemistry, Rajarajeswari Medical College and Hospital, Bengaluru, Karnataka, India.
3. Assistant Professor, Department of Biochemistry, Rajarajeswari Medical College and Hospital, Bangalore, Karnataka, India.
4. Professor, Department of Paediatrics, Rajarajeswari Medical College and Hospital, Bangalore, Karnataka, India.
5. Professor, Department of Pathology, Rajarajeswari Medical College and Hospital, Bangalore, Karnataka, India.
Correspondence Address :
Dr. AN Shruthi,
Assistant Professor, Department of Biochemistry, Rajarajeswari Medical College and Hospital, Bangalore, Karnataka, India.
E-mail: shruthisomrao@gmail.com
Abstract
Subcutaneous Fat Necrosis (SCFN) is an uncommon transient panniculitis more commonly seen in first week of newborn life. Hypercalcaemia is tell-tale of this disorder, resulting in consequences like metabolic derangements, polyuria, seizures, vomiting, nephrocalcinosis and cardiovascular disturbances contributing to morbidity and mortality of SCFN. This is a case report of an eight-week-old male infant who presented with hypercalcaemia and multiple nodules all over the body. Histopathology is the gold standard method which helps in diagnosis and evaluation of a patient with SCFN. In this case, histopathological report revealed focal areas of fat necrosis in the fat lobules along with lobular panniculitis with infiltration of lymphocytes, histocytes, fibroblasts and multinucleated giant cells. Its granules were suggestive of SCFN. The diagnosis of SCFN was confirmed by skin biopsy and additionally supported by hypercalcaemia. This study highlights the importance of performing detailed skin examination for the evaluation of patients until the resolution of hypercalcaemia and skin lesions. In this case, hypercalcaemia resolved by the end of 12th week of life. Though, it is a benign and self-limiting condition, educating and creating awareness among the parents is of utmost importance and to prevent renal and cardiac complications associated with hypercalcaemia. Rehydration therapy, calcium and Vitamin D restricted diet are the modes of treatment for treating this condition.
Keywords
Hypertriglyceridemia, Lobular panniculitis, Neonatal sepsis, Rehydration, Thrombocytopenia
Case Report
An eight-week-old male infant referred from outside clinic (suspecting neonatal sepsis for further management) was admitted to the paediatric unit. The infant presented with multiple nodules since 2nd week of life on the nape of the neck which increased all over the body in size and number. The infant had history of fever, failure to thrive and refusal of feeds since 7th week of life. Birth history revealed that he was delivered by emergency caesarean section due to foetal distress and low birth weight (1520 grams) at 37th week of gestation. Soon after birth, the baby experienced severe peripheral asphyxia secondary to meconium aspiration which required intubation and suction. Appearance, Pulse, Grimace, Activity, and Respiration (APGAR) Score (1) was 2 and 8 at 1 and 5 minute, respectively. Positive pressure ventilation and positive end expiratory pressure were administered under intensive care for a week. The newborn did not receive body cooling therapeutic hypothermia. Mother noticed nodules over the nape of the neck during second week of life, which gradually increased in size and number, spreading all over the body in a span of four weeks, which gradually decreased over the next two weeks. There was no family history of hypertriglyceridemia.
On the day of admission the infant was febrile: temperature- 99.5°F (Fahrenheit), pulse-130/minute, respiratory rate-46/minute, cardiovascular, respiratory and central nervous system examination normal, per abdomen-soft, liver palpable. Multiple well defined palpable nodules measuring about 1×1 cm to 3×3 cm were present predominantly over the upper back, cheeks, upper limbs (Table/Fig 1) and lower limbs. Lesions were non tender and not attached to the deeper structures. There was no local rise of temperature. Differential diagnoses were sepsis, SCFN or sclerema neonatorum. The clinical evaluation and skin biopsy confirmed the diagnosis of SCFN and was additionally supported by hypercalcaemia (Table/Fig 2).
Reference ranges of above parameters were extracted from Beckman Coulter kit insert (information sheet) (2),(3).
The baby was admitted for 12 days. During the stay in the hospital all biochemical and haematological investigations were repeated to monitor the progress of the baby. All parameters remained normal except for few parameters which are mentioned in the (Table/Fig 3).
Histopathology report: In the upper right arm, the dermis showed normal adnexal structures. Subcutaneous fat showed focal areas of fat necrosis in the fat lobules. Lobular panniculitis with infiltration of lymphocytes, histocytes, fibroblasts and multinucleated giant cells (Table/Fig 4). Its granules suggestive of SCFN. The diagnosis 2was SCFN confirmed by skin biopsy of nodule and hypercalcaemia (20 mg/dL). Blood culture and clinical stability of the infant ruled out the sepsis.
Ultrasound of abdomen and radiograph of chest reports were normal. On hospitalisation, the infant (weight-3.28 kg) was treated for urinary tract infection with appropriate antibiotics injections intravenously every 12th hourly (ceftriaxone 160 mg for seven days from day one and amikacin 25 mg for three days from day third (Escherichia coli susceptible to amikacin). Dehydration was corrected with intravenous fluids {DNS (Dextrose and Sodium Chloride) 6 mL per hour}. The infant was treated for fever by anamol 80 mg suppository 3/4th per rectal and dolo drops 0.4 mL (100 mg/mL) as and when required. The infant was initially started with paladai feeds and mother was encouraged to breast feed her baby. Cutaneous nodular lesions continued to regress and the infant was physically stable at the time of discharge. The mother was advised to exclusively breast feed her baby till six months and not to start complimentary feeds like ragi porridge and soup of green leafy vegetables. The serum calcium level was 20 mg/dL on the day of discharge. The baby was followed-up to six weeks periodically from day of discharge. Serum calcium level reduced to normal (10.5 mg/dL) by the end of 12th week of life without any complications.
Discussion
The SCFN is an uncommon, self-resolving panniculitis commonly seen in full term or post term newborns in the first few weeks of life (4). The aetiology of the disease is unclear. It usually presents with nodules or plaques on skin of arms, cheeks, upper back, and thighs. In spite of a favourable prognosis, it may also be complicated with metabolic and haematological alterations like hypercalcaemia, hypertriglyceridemia, hypoglycaemia or thrombocytopenia (4),(5),(6) which should be managed by timely intervention (6),(7),(8).
The SCFN is typically seen in maternal or neonatal stress, including maternal diabetes, cord prolapse, meconium aspiration, perinatal asphyxia, neonatal sepsis or therapeutic hypothermia (9),(10),(11). The subcutaneous lesions are firm, erythematous or purplish nodules present on back, shoulders and upper limbs and thighs (4),(7). The pathogenesis of SCFN remains unclear. It has been postulated that the normal blood supply to the neonatal fat tissue is affected during neonatal distress, which results in hypoxia and hypothermia leading to inflammation and necrosis in fat tissue (9),(12),(13). The newborn fat consists of more amount of saturated fatty acids compared to adult fat, because of its higher melting point associated with the tendency for solidification and crystallisation (5),(9). The histopathology contributes to diagnosis with characteristic lobular panniculitis, mixed inflammatory cell infiltrate and radially arranged crystals (4),(6),(12). The skin lesion does not require any treatment as the disease is self-resolving (7),(14),(15).
Hypercalcaemia (Serum Ca >10.5 mg/dL) (16) was diagnosed in the present case (Serum Ca-20 mg/dL). The pathogenesis for hypercalcaemia is not clear (17) and research has shown
many mechanisms which include: a) increased prostaglandin activity leading to osteoclast activation; b) calcium released from necrotic fat cells; c) increased production of activated vitamin D by macrophages which causes release of calcium from bone and
increased absorption of calcium from the gut (18),(19),(20). Farooque A et al., demonstrated the presence of extrarenal 1α-hydroxylase in immune cells associated with SCFN (21). Hypercalcaemia can lead to gastrointestinal, neurological and cardiac life-threatening complications. Hypercalcaemia may reduce renal concentrating capacity presenting with polyuria and dehydration leading to kidney failure and metastatic calcifications (4),(7),(12),(15). It is vital to monitor the patient’s serum calcium levels for at least six months after the diagnosis (7),(12). For this case, infant was followed-up for a period of three months until serum calcium returned to normal (10.5 mg/dL). Hypercalcaemia treatment includes aggressive hydration, drugs like furosemide and prednisolone to decrease serum calcium and low vitamin D and calcium diet (14),(22). In 76% of cases resolution of hypercalcaemia seen within 4 weeks of detection (23).
In this case, the infant’s serum was turbid at eighth week. The observed hypertriglyceridemia may be due to the resolution of nodules and mobilisation of lipid from necrotic adipose tissue (4),(12),(24). Thrombocytopenia is known to be associated with SCFN due to sequestration of platelets in subcutaneous tissue (12),(18). In this case, thrombocytosis was present which was similar to cases observed by Lorenzo C et al., and Sahni M et al., (10),(11). It may be attributed to the reactive inflammatory response of SCFN (10),(11). The present case showed multiple features of SCFN which is supported by a skin biopsy in the clinical diagnosis. Serum parathyroid hormone and vitamin D levels was not measured as the patient attenders could not afford the costs which would have further strengthened our laboratory diagnosis.
Conclusion
The SCFN is a rare self-limiting condition. Early diagnosis and appropriate intervention are required to prevent the complication that arises from SCFN. Hypercalcaemia is a potentially lifethreatening complication that occurs in this subset of patients. Periodic monitoring until the resolution of lesions and hypercalcaemia is required. This helps in reducing morbidity and mortality for SCFN in the newborn. Educating and reassuring the parents regarding its self-limiting nature is also an important part of the treatment protocol. This case highlights the importance of early recognition, initial management. This case presentation can be used as reference for SCFN cases at tertiary care hospital.
Acknowledgement
Authors would like to acknowledge the child’s parents for providing detailed information and co-operating by giving all the relevant information. Authors would like to extend their heartiest thanks with deep sense of gratitude and respect to Dr. Akshay (Dermatology, RRMCH) and all those who provided us immense help and guidance.
Reference
| 1. | Paul VK. Ghai. Essential Pediatrics. 8th ed. CBS Publishers Pvt Ltd. 2019(1) chapter 8, Newborn Infants; Pp.126.
| 2. | Tietz NW. Fundamentals of Clinical Chemistry, 3rd Edition, WB Saunders, 1987;2:720.
| 3. | Bauer PJ. Affinity and stoichiometry of calcium binding by arsenazo III. Anal Biochem. 1981;110(1):61-72.
[ CrossRef] | 4. | Chrysaidou K, Sargiotis G, Karava V, Liasis D, Gourvas V, Moutsanas V, et al. Subcutaneous fat necrosis and hypercalcaemia with nephrocalcinosis in infancy: Case report and review of the literature. Children. 2021;8(5):374.
[ CrossRef] [ PubMed] | 5. | Janssens PM, Vonk J, Demacker PN. Hypertriglyceridaemia in a case of subcutaneous fat necrosis in a newborn. Annals of Clinical Biochemistry. 1993;30(5):482-84.
[ CrossRef] [ PubMed] | 6. | Alsofyani KA. Neonatal subcutaneous fat necrosis with hypercalcaemia treatment using calcitonin. Saudi Medical Journal. 2018;39(6):622.
[ CrossRef] [ PubMed] | 7. | Velasquez JH, Mendez MD. Newborn subcutaneous fat necrosis. Stat Pearls. 2021;15.
| 8. | Kannenberg SM, Jordaan HF, Visser WI, Ahmed F, Bezuidenhout AF. Report of 2 novel presentations of subcutaneous fat necrosis of the newborn. Dermatopathology. 2019;6(2):147-52.
[ CrossRef] [ PubMed] | 9. | Lara LG, Villa AV, Rivas MM, Capella MS, Prada F, Ensenat MA. Subcutaneous fat necrosis of the newborn: Report of five cases. Pediatrics & Neonatology. 2017;58(1):85-88.
[ CrossRef] [ PubMed] | 10. | Lorenzo C, Romana A, Matias J, Calhau P. Subcutaneous fat necrosis of the newborn-An atypical case with typical complications. Clinical Case Reports. 2021;9(4):2069-73.
[ CrossRef] [ PubMed] | 11. | Sahni M, Patel P, Muthukumar A. Severe thrombocytosis in a newborn with subcutaneous fat necrosis and maternal chorioamnionitis. Case Reports in Hematology. 2020;21:2020.
[ CrossRef] [ PubMed] | 12. | Choudhary R, Sachdeva G, Katoch G. Neonatal subcutaneous fat necrosis as a close differential of neonatal sepsis: Case report and review of literature. Indian Journal of Paediatric Dermatology. 2020;21(1):11.
[ CrossRef] | 13. | Mitra S, Dove J, Somisetty SK. Subcutaneous fat necrosis in newborn- An unusual case and review of literature. Eur J Pediatr. 2011;170(9):1107-10.
[ CrossRef] [ PubMed] | 14. | Verma S, Bailey SM, Mally PV, Wachtel EV. Subcutaneous fat necrosis and hypercalcaemia after therapeutic hypothermia in patients with hypoxic-ischemic encephalopathy: A case series. Cureus. 2018;10(7):e3074.
[ CrossRef] | 15. | Garg A, Singhal R, Chaudhary SS. Neonatal hypercalcaemia secondary to subcutaneous fat necrosis presenting as severe dehydration. Indian Journal of Paediatric Dermatology. 2018;19(2):146.
| 16. | Khadilkar A, Khadilkar V, Chinnappa J, Rathi N, Khadgawat R, Balasubramanian S, et al. Prevention and treatment of vitamin D and calcium deficiency in children and adolescents: Indian Academy of Pediatrics (IAP) Guidelines. Indian Pediatrics. 2017;54(7):567-73.
[ CrossRef] [ PubMed] | 17. | Dyess RJ, Gandham PP, Thrasher BJ. Successfully treating hypercalcaemia secondary to subcutaneous fat necrosis with pamidronate: A case series. International Journal of Clinical Pediatrics. 2021;10(1):06-09.
[ CrossRef] | 18. | Dudink J, Walther FJ, Beekman RP. Subcutaneous fat necrosis of the newborn: Hypercalcaemia with hepatic and atrial myocardial calcification. Archives of Disease in Childhood-Fetal and Neonatal Edition. 2003;88(4):F343-45.
[ CrossRef] [ PubMed] | 19. | Aye MS, Mahaseth M, Rozzelle A, Bhagat I, Agarwal P. Newborn with enlarged erythematous mass on back: Case report and review of medical literature. Global Pediatric Health. 2018;5:2333794X18803552.
[ CrossRef] [ PubMed] | 20. | Chikaodinaka AA, Jude AC. Subcutaneous fat necrosis of the newborn: A case report of a term infant presenting with malaise and fever at age of 9 weeks. Case Reports in Pediatrics. 2015;8;2015.
[ CrossRef] [ PubMed] | 21. | Farooque A, Moss C, Zehnder D, Hewison M, Shaw NJ. Expression of 25-hydroxyvitamin D3-1α-hydroxylase in subcutaneous fat necrosis. British Journal of Dermatology. 2009;160(2):423-25.
[ CrossRef] [ PubMed] | 22. | Rubin G, Spagnut G, Morandi F, Valerio E, Cutrone M. Subcutaneous fat necrosis of the newborn. Clinical Case Reports. 2015;3(12):1017.
[ CrossRef] [ PubMed] | 23. | Stefanko NS, Drolet BA. Subcutaneous fat necrosis of the newborn and associated hypercalcaemia: A systematic review of the literature. Pediatric Dermatology. 2019;36(1):24-30.
[ CrossRef] | 24. | Canpolat N, Ozdil M, Kuruğoğlu S, Çalişkan S, Sever L. Nephrocalcinosis as a complication of subcutaneous fat necrosis of the newborn. Turk J Pediatr. 2012;1;54(6):667-70. |
DOI: 10.7860/JCDR/2022/54891.16405
Date of Submission: Jan 11, 2022
Date of Peer Review: Feb 10, 2022
Date of Acceptance: Mar 23, 2022
Date of Publishing: May 01, 2022
AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. Yes
PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Jan 17, 2022
• Manual Googling: Mar 22, 2022
• iThenticate Software: Apr 19, 2022 (17%)
ETYMOLOGY: Author Origin
|